Adverse Events and Factors Associated with Potentially Avoidable Use of General Anesthesia in Cesarean Deliveries

Compared with neuraxial anesthesia, general anesthesia for cesarean delivery is associated with increased risk of maternal adverse events. Reducing avoidable general anesthetics for cesarean delivery may improve safety of obstetric anesthesia care. This study examined adverse events, trends, and fac...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Anesthesiology (Philadelphia) Ročník 130; číslo 6; s. 912
Hlavní autoři:	Guglielminotti, Jean, Landau, Ruth, Li, Guohua
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.06.2019
Témata:	Adult Anesthesia, General - adverse effects Anesthesia, General - trends Anesthesia, Obstetrical - adverse effects Anesthesia, Obstetrical - trends Cesarean Section - adverse effects Cesarean Section - trends Drug-Related Side Effects and Adverse Reactions - diagnosis Drug-Related Side Effects and Adverse Reactions - physiopathology Drug-Related Side Effects and Adverse Reactions - prevention & control Female Humans Pregnancy Retrospective Studies
ISSN:	1528-1175, 1528-1175
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Compared with neuraxial anesthesia, general anesthesia for cesarean delivery is associated with increased risk of maternal adverse events. Reducing avoidable general anesthetics for cesarean delivery may improve safety of obstetric anesthesia care. This study examined adverse events, trends, and factors associated with potentially avoidable general anesthetics for cesarean delivery. This retrospective study analyzed cesarean delivery cases without a recorded indication for general anesthesia or contraindication to neuraxial anesthesia in New York State hospitals, 2003 to 2014. Adverse events included anesthesia complications (systemic, neuraxial-related, and drug-related), surgical site infection, venous thromboembolism, and the composite of death or cardiac arrest. Anesthesia complications were defined as severe if associated with death, organ failure, or prolonged hospital stay. During the study period, 466,014 cesarean deliveries without a recorded indication for general anesthesia or contraindication to neuraxial anesthesia were analyzed; 26,431 were completed with general anesthesia (5.7%). The proportion of avoidable general anesthetics decreased from 5.6% in 2003 to 2004 to 4.8% in 2013 to 2014 (14% reduction; P < 0.001). Avoidable general anesthetics were associated with significantly increased risk of anesthesia complications (adjusted odds ratio, 1.6; 95% CI, 1.4 to 1.9), severe complications (adjusted odds ratio, 2.9; 95% CI, 1.6 to 5.2), surgical site infection (adjusted odds ratio, 1.7; 95% CI, 1.5 to 2.1), and venous thromboembolism (adjusted odds ratio, 1.9; 95% CI, 1.3 to 3.0), but not of death or cardiac arrest. Labor neuraxial analgesia rate was one of the most actionable hospital-level factors associated with avoidable general anesthetics. Relative to hospitals with a rate greater than or equal to 75%, the adjusted odds ratio of avoidable general anesthetics increased to 1.3 (95% CI, 1.2 to 1.4), 1.6 (95% CI, 1.5 to 1.7), and 3.2 (95% CI, 3.0 to 3.5) as the rate decreased to 50 to 74.9%, 25 to 49.9%, and less than 25%, respectively. Compared with neuraxial anesthesia, avoidable general anesthetics are associated with increased risk of adverse maternal outcomes.
AbstractList	Compared with neuraxial anesthesia, general anesthesia for cesarean delivery is associated with increased risk of maternal adverse events. Reducing avoidable general anesthetics for cesarean delivery may improve safety of obstetric anesthesia care. This study examined adverse events, trends, and factors associated with potentially avoidable general anesthetics for cesarean delivery. This retrospective study analyzed cesarean delivery cases without a recorded indication for general anesthesia or contraindication to neuraxial anesthesia in New York State hospitals, 2003 to 2014. Adverse events included anesthesia complications (systemic, neuraxial-related, and drug-related), surgical site infection, venous thromboembolism, and the composite of death or cardiac arrest. Anesthesia complications were defined as severe if associated with death, organ failure, or prolonged hospital stay. During the study period, 466,014 cesarean deliveries without a recorded indication for general anesthesia or contraindication to neuraxial anesthesia were analyzed; 26,431 were completed with general anesthesia (5.7%). The proportion of avoidable general anesthetics decreased from 5.6% in 2003 to 2004 to 4.8% in 2013 to 2014 (14% reduction; P < 0.001). Avoidable general anesthetics were associated with significantly increased risk of anesthesia complications (adjusted odds ratio, 1.6; 95% CI, 1.4 to 1.9), severe complications (adjusted odds ratio, 2.9; 95% CI, 1.6 to 5.2), surgical site infection (adjusted odds ratio, 1.7; 95% CI, 1.5 to 2.1), and venous thromboembolism (adjusted odds ratio, 1.9; 95% CI, 1.3 to 3.0), but not of death or cardiac arrest. Labor neuraxial analgesia rate was one of the most actionable hospital-level factors associated with avoidable general anesthetics. Relative to hospitals with a rate greater than or equal to 75%, the adjusted odds ratio of avoidable general anesthetics increased to 1.3 (95% CI, 1.2 to 1.4), 1.6 (95% CI, 1.5 to 1.7), and 3.2 (95% CI, 3.0 to 3.5) as the rate decreased to 50 to 74.9%, 25 to 49.9%, and less than 25%, respectively. Compared with neuraxial anesthesia, avoidable general anesthetics are associated with increased risk of adverse maternal outcomes. Compared with neuraxial anesthesia, general anesthesia for cesarean delivery is associated with increased risk of maternal adverse events. Reducing avoidable general anesthetics for cesarean delivery may improve safety of obstetric anesthesia care. This study examined adverse events, trends, and factors associated with potentially avoidable general anesthetics for cesarean delivery.BACKGROUNDCompared with neuraxial anesthesia, general anesthesia for cesarean delivery is associated with increased risk of maternal adverse events. Reducing avoidable general anesthetics for cesarean delivery may improve safety of obstetric anesthesia care. This study examined adverse events, trends, and factors associated with potentially avoidable general anesthetics for cesarean delivery.This retrospective study analyzed cesarean delivery cases without a recorded indication for general anesthesia or contraindication to neuraxial anesthesia in New York State hospitals, 2003 to 2014. Adverse events included anesthesia complications (systemic, neuraxial-related, and drug-related), surgical site infection, venous thromboembolism, and the composite of death or cardiac arrest. Anesthesia complications were defined as severe if associated with death, organ failure, or prolonged hospital stay.METHODSThis retrospective study analyzed cesarean delivery cases without a recorded indication for general anesthesia or contraindication to neuraxial anesthesia in New York State hospitals, 2003 to 2014. Adverse events included anesthesia complications (systemic, neuraxial-related, and drug-related), surgical site infection, venous thromboembolism, and the composite of death or cardiac arrest. Anesthesia complications were defined as severe if associated with death, organ failure, or prolonged hospital stay.During the study period, 466,014 cesarean deliveries without a recorded indication for general anesthesia or contraindication to neuraxial anesthesia were analyzed; 26,431 were completed with general anesthesia (5.7%). The proportion of avoidable general anesthetics decreased from 5.6% in 2003 to 2004 to 4.8% in 2013 to 2014 (14% reduction; P < 0.001). Avoidable general anesthetics were associated with significantly increased risk of anesthesia complications (adjusted odds ratio, 1.6; 95% CI, 1.4 to 1.9), severe complications (adjusted odds ratio, 2.9; 95% CI, 1.6 to 5.2), surgical site infection (adjusted odds ratio, 1.7; 95% CI, 1.5 to 2.1), and venous thromboembolism (adjusted odds ratio, 1.9; 95% CI, 1.3 to 3.0), but not of death or cardiac arrest. Labor neuraxial analgesia rate was one of the most actionable hospital-level factors associated with avoidable general anesthetics. Relative to hospitals with a rate greater than or equal to 75%, the adjusted odds ratio of avoidable general anesthetics increased to 1.3 (95% CI, 1.2 to 1.4), 1.6 (95% CI, 1.5 to 1.7), and 3.2 (95% CI, 3.0 to 3.5) as the rate decreased to 50 to 74.9%, 25 to 49.9%, and less than 25%, respectively.RESULTSDuring the study period, 466,014 cesarean deliveries without a recorded indication for general anesthesia or contraindication to neuraxial anesthesia were analyzed; 26,431 were completed with general anesthesia (5.7%). The proportion of avoidable general anesthetics decreased from 5.6% in 2003 to 2004 to 4.8% in 2013 to 2014 (14% reduction; P < 0.001). Avoidable general anesthetics were associated with significantly increased risk of anesthesia complications (adjusted odds ratio, 1.6; 95% CI, 1.4 to 1.9), severe complications (adjusted odds ratio, 2.9; 95% CI, 1.6 to 5.2), surgical site infection (adjusted odds ratio, 1.7; 95% CI, 1.5 to 2.1), and venous thromboembolism (adjusted odds ratio, 1.9; 95% CI, 1.3 to 3.0), but not of death or cardiac arrest. Labor neuraxial analgesia rate was one of the most actionable hospital-level factors associated with avoidable general anesthetics. Relative to hospitals with a rate greater than or equal to 75%, the adjusted odds ratio of avoidable general anesthetics increased to 1.3 (95% CI, 1.2 to 1.4), 1.6 (95% CI, 1.5 to 1.7), and 3.2 (95% CI, 3.0 to 3.5) as the rate decreased to 50 to 74.9%, 25 to 49.9%, and less than 25%, respectively.Compared with neuraxial anesthesia, avoidable general anesthetics are associated with increased risk of adverse maternal outcomes.CONCLUSIONSCompared with neuraxial anesthesia, avoidable general anesthetics are associated with increased risk of adverse maternal outcomes.
Author	Guglielminotti, Jean Landau, Ruth Li, Guohua
Author_xml	– sequence: 1 givenname: Jean surname: Guglielminotti fullname: Guglielminotti, Jean organization: From the Department of Anesthesiology, Columbia University College of Physicians and Surgeons, New York, New York (J.G., R.L., G.L.) French Institute of Health and Medical Research (INSERM), Mixed Research Unit (UMR) 1137, Infection Antimicrobials Modelling Evolution (IAME), Paris, France (J.G.) Department of Epidemiology, Columbia University Mailman School of Public Health, New York, New York (G.L.) – sequence: 2 givenname: Ruth surname: Landau fullname: Landau, Ruth – sequence: 3 givenname: Guohua surname: Li fullname: Li, Guohua
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30789362$$D View this record in MEDLINE/PubMed
BookMark	eNpNkEtPwzAQhC0Eog_4Bwj5yCXFjyROjlFpC1IFHOi52thr1Si12zgt6r8nEkXqXnYP3-yMZkSuffBIyANnE85K9Vwt3yfsYkQuyisy5JkoEs5Vdn1xD8goxu8eUpksbslAMlWUMhdDsq_MEduIdHZE30UK3tA56C60kVYxBu2gQ0N_XLehn6HrGQdNc6LVMTgDdYN01YuDpQv02EJDK4-x22B0QJ2nU4zQInj6go3rjRzGO3JjoYl4f95jsprPvqavyfJj8TatlolOM1UmloGsc1ZCqbi2meVKF7WslZUMrRY5MxysEba2zFhjU5HmNQMwWaGtkhLFmDz9_d21YX_oQ623LmpsGvAYDnEteJFmUqm07NHHM3qot2jWu9ZtoT2t_2sSv9KCblQ
CitedBy_id	crossref_primary_10_1213_ANE_0000000000004663 crossref_primary_10_1016_j_jopan_2025_05_176 crossref_primary_10_1097_ACO_0000000000000925 crossref_primary_10_1186_s12884_023_05348_4 crossref_primary_10_1213_ANE_0000000000005117 crossref_primary_10_31083_j_ceog4805177 crossref_primary_10_3390_jpm14060633 crossref_primary_10_1097_GRF_0000000000000669 crossref_primary_10_5812_aapm_162647 crossref_primary_10_36290_aim_2019_071 crossref_primary_10_3390_jpm12060970 crossref_primary_10_1111_anae_15368 crossref_primary_10_1038_s41598_022_22165_5 crossref_primary_10_1016_j_accpm_2023_101310 crossref_primary_10_1161_CIR_0000000000001121 crossref_primary_10_7759_cureus_69852 crossref_primary_10_1016_j_ijoa_2025_104689 crossref_primary_10_1186_s12871_020_0934_0 crossref_primary_10_1016_j_ijoa_2019_05_001 crossref_primary_10_2147_JPR_S428332 crossref_primary_10_1016_j_redare_2024_07_007 crossref_primary_10_3390_healthcare10010023 crossref_primary_10_1186_s12871_024_02412_0 crossref_primary_10_1111_anae_16204 crossref_primary_10_1016_j_ijoa_2025_104696 crossref_primary_10_1097_01_aoa_0000990500_49734_ca crossref_primary_10_1016_j_anclin_2024_09_003 crossref_primary_10_1007_s00404_021_06025_7 crossref_primary_10_1097_01_aoa_0000575036_25826_9a crossref_primary_10_1097_ALN_0000000000005507 crossref_primary_10_1155_2022_2866188 crossref_primary_10_1111_anae_15594 crossref_primary_10_3390_antibiotics12010092 crossref_primary_10_1016_j_bja_2020_06_021 crossref_primary_10_1080_08998280_2022_2086789 crossref_primary_10_1177_23821205241229778 crossref_primary_10_1213_ANE_0000000000005496 crossref_primary_10_1213_ANE_0000000000006108 crossref_primary_10_1007_s00540_024_03411_8 crossref_primary_10_1213_ANE_0000000000007314 crossref_primary_10_1016_j_anclin_2024_02_002 crossref_primary_10_1016_j_ogc_2020_11_005 crossref_primary_10_1016_j_jcjq_2023_06_007 crossref_primary_10_1136_rapm_2020_102441 crossref_primary_10_1097_ACO_0000000000001242 crossref_primary_10_1097_ACO_0000000000001001 crossref_primary_10_1016_j_bpa_2022_04_007 crossref_primary_10_1097_AIA_0000000000000323 crossref_primary_10_1097_ALN_0000000000005576 crossref_primary_10_1213_ANE_0000000000005937 crossref_primary_10_1016_j_anclin_2021_08_011 crossref_primary_10_1016_j_bpa_2024_11_003 crossref_primary_10_1213_ANE_0000000000006750 crossref_primary_10_1016_j_accpm_2021_100938 crossref_primary_10_1213_ANE_0000000000004851 crossref_primary_10_1097_ACO_0000000000001488 crossref_primary_10_3390_medicina60030358 crossref_primary_10_1053_j_jvca_2023_09_027 crossref_primary_10_1016_j_jogoh_2025_102932 crossref_primary_10_1097_ACO_0000000000001135 crossref_primary_10_1016_j_ijoa_2022_103564 crossref_primary_10_1111_1471_0528_17686 crossref_primary_10_1016_j_accpm_2023_101269 crossref_primary_10_1016_j_accpm_2023_101302 crossref_primary_10_7759_cureus_19729 crossref_primary_10_1097_ALN_0000000000004632 crossref_primary_10_1515_jpm_2019_0412 crossref_primary_10_1213_ANE_0000000000005433 crossref_primary_10_1016_j_anclin_2021_08_003 crossref_primary_10_7759_cureus_35910 crossref_primary_10_1213_ANE_0000000000006764 crossref_primary_10_1016_j_bja_2020_03_010 crossref_primary_10_3390_medicina59010044 crossref_primary_10_1016_j_ijcchd_2021_100145 crossref_primary_10_1016_j_ijoa_2025_104761 crossref_primary_10_1016_j_jclinane_2024_111689 crossref_primary_10_1097_ALN_0000000000004743 crossref_primary_10_1016_j_ijoa_2022_103546 crossref_primary_10_1111_ppe_12847 crossref_primary_10_1007_s40140_021_00437_6 crossref_primary_10_1097_EJA_0000000000002252 crossref_primary_10_1186_s44158_025_00257_8 crossref_primary_10_1053_j_jvca_2021_03_033 crossref_primary_10_1111_anae_15313 crossref_primary_10_1016_j_jclinane_2024_111398 crossref_primary_10_1213_XAA_0000000000001777 crossref_primary_10_7759_cureus_45170 crossref_primary_10_3389_fnins_2024_1407301 crossref_primary_10_1016_j_anclin_2020_01_006 crossref_primary_10_1186_s12871_025_03185_w crossref_primary_10_1055_a_2011_8259 crossref_primary_10_1097_AIA_0000000000000360 crossref_primary_10_1016_j_jogoh_2022_102468 crossref_primary_10_1097_ALN_0000000000002708 crossref_primary_10_1213_ANE_0000000000007510 crossref_primary_10_1007_s00540_023_03287_0 crossref_primary_10_1080_08998280_2023_2223077 crossref_primary_10_1001_jamanetworkopen_2023_50825 crossref_primary_10_1016_j_ijoa_2021_103171 crossref_primary_10_1111_anae_15427 crossref_primary_10_1016_j_ajog_2025_05_018 crossref_primary_10_1001_jamanetworkopen_2022_0137 crossref_primary_10_1213_ANE_0000000000004800 crossref_primary_10_1016_j_anclin_2023_03_008 crossref_primary_10_1213_ANE_0000000000006428 crossref_primary_10_1016_j_ijoa_2024_104267 crossref_primary_10_1097_ALN_0000000000004961 crossref_primary_10_3390_life15081158 crossref_primary_10_1016_j_clp_2019_08_009 crossref_primary_10_1016_j_ijoa_2020_10_003 crossref_primary_10_1186_s12890_023_02355_1 crossref_primary_10_1186_s12879_025_11217_6 crossref_primary_10_1016_j_semperi_2020_151277 crossref_primary_10_1016_j_bpa_2023_02_005 crossref_primary_10_3389_fphar_2024_1360691 crossref_primary_10_1136_rapm_2024_105766 crossref_primary_10_3390_jcm11164808
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1097/ALN.0000000000002629
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
EISSN	1528-1175
ExternalDocumentID	30789362
Genre	Research Support, U.S. Gov't, P.H.S Journal Article
GrantInformation_xml	– fundername: AHRQ HHS grantid: R03 HS025787
GroupedDBID	--- -~X .-D .3C .55 .GJ .XZ .Z2 01R 026 0R~ 1CY 1J1 23M 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6J9 71W 77Y 7O~ AAAAV AAAXR AAEJM AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABVCZ ABXVJ ABZAD ACCJW ACDDN ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACLED ACOAL ACRZS ACWDW ACWRI ACXJB ACXNZ ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFDTB AFEXH AFFNX AFSOK AFUWQ AGINI AHOMT AHQNM AHRYX AHVBC AHXIK AIJEX AINUH AJCLO AJIOK AJJEV AJNWD AJNYG AJRGT AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AWKKM BAWUL BCGUY BOYCO BQLVK BS7 BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DUNZO E.X EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ J5H JF7 JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI L-C L7B M18 N4W N9A NPM N~7 N~B N~M O9- OAG OAH OB3 OBH OCUKA ODA ODMTH ODZKP OGROG OHH OHYEH OJAPA OK1 OL1 OLB OLG OLH OLL OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OVOZU OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PKN R58 RIG RLZ S4R S4S T8P TEORI TR2 TSPGW TWZ V2I W2D W3M WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YOC YQI YQJ ZFV ZGI ZXP ZY1 ZZMQN 7X8 AAFWJ ABPXF ABXYN ABZZY ACDOF ACZKN ADGHP ADKSD ADSXY AFBFQ AFMBP AFNMH AHQVU AOQMC
ID	FETCH-LOGICAL-c4579-f0a3b609a971cf5f17c8b3b7f30efc260d1afd2fbf0dfdf4246b0aad58cf733e2
IEDL.DBID	7X8
ISICitedReferencesCount	116
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000467856100010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1528-1175
IngestDate	Mon Sep 08 10:06:49 EDT 2025 Wed Feb 19 02:25:37 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	6
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4579-f0a3b609a971cf5f17c8b3b7f30efc260d1afd2fbf0dfdf4246b0aad58cf733e2
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://www.ncbi.nlm.nih.gov/pmc/articles/9922091
PMID	30789362
PQID	2184537749
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2184537749 pubmed_primary_30789362
PublicationCentury	2000
PublicationDate	2019-06-00 20190601
PublicationDateYYYYMMDD	2019-06-01
PublicationDate_xml	– month: 06 year: 2019 text: 2019-06-00
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Anesthesiology (Philadelphia)
PublicationTitleAlternate	Anesthesiology
PublicationYear	2019
References	30985305 - Anesthesiology. 2019 Jun;130(6):864-866
References_xml	– reference: 30985305 - Anesthesiology. 2019 Jun;130(6):864-866
SSID	ssj0007538
Score	2.594473
Snippet	Compared with neuraxial anesthesia, general anesthesia for cesarean delivery is associated with increased risk of maternal adverse events. Reducing avoidable...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	912
SubjectTerms	Adult Anesthesia, General - adverse effects Anesthesia, General - trends Anesthesia, Obstetrical - adverse effects Anesthesia, Obstetrical - trends Cesarean Section - adverse effects Cesarean Section - trends Drug-Related Side Effects and Adverse Reactions - diagnosis Drug-Related Side Effects and Adverse Reactions - physiopathology Drug-Related Side Effects and Adverse Reactions - prevention & control Female Humans Pregnancy Retrospective Studies
Title	Adverse Events and Factors Associated with Potentially Avoidable Use of General Anesthesia in Cesarean Deliveries
URI	https://www.ncbi.nlm.nih.gov/pubmed/30789362 https://www.proquest.com/docview/2184537749
Volume	130
WOSCitedRecordID	wos000467856100010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07a8MwEBZt06FLH_SVvlChq4kt2ZY1FZPGdEhNhqZkM7IeYAh2UqeB_vue_CBbKVSDNoHRne--O919h9CTJ01uWdgdJkAMPvhMh7NAO5R6xBORkqRJ5nxMWZpGiwWfdQm3uiur7G1iY6hVJW2OfGRDkYACWOHPq7Vjp0bZ19VuhMY-GlCAMlar2WLHFg5QvGmFCwhESuAn-9Y5zkbxNG2pC7tFwt9AZuNskpP_fuYpOu5gJo5bvThDe7o8R-tm-nKt8cQWOdZYlAon7bwd3ItJK2xTs3hWbWwdkVguv3G8rQplW6zwHA5XBndc1TgGOwkAsi4ELko81rUACFriF7201R4Qg1-geTJ5H7863cgFR_oB445xBc1DlwvOQIqB8ZiMcpozQ11tJMQ-yhNGEZMbVxllfOKHuSuECiJpGKWaXKKDsir1NcIUtIP6inraWAYawTmJAimJ8T0REhEO0WN_gxmotH2nEKWuvupsd4dDdNWKIVu13BsZtfT44HRv_nD6Fh0BvOFtYdcdGhj4ofU9OpTbTVF_PjS6Ans6e_sBtlrJoA
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adverse+Events+and+Factors+Associated+with+Potentially+Avoidable+Use+of+General+Anesthesia+in+Cesarean+Deliveries&rft.jtitle=Anesthesiology+%28Philadelphia%29&rft.au=Guglielminotti%2C+Jean&rft.au=Landau%2C+Ruth&rft.au=Li%2C+Guohua&rft.date=2019-06-01&rft.eissn=1528-1175&rft.volume=130&rft.issue=6&rft.spage=912&rft_id=info:doi/10.1097%2FALN.0000000000002629&rft_id=info%3Apmid%2F30789362&rft_id=info%3Apmid%2F30789362&rft.externalDocID=30789362
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1528-1175&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1528-1175&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1528-1175&client=summon